Price
No data yet.
Social Signal Score
Analyst Ratings
20 analystsRevenue
$5.51B+26.85%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Peter J. Arduini
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 54,000
- Beta
- 0.77
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.00
Financials
Revenue
$5.51B+26.9%Net Income
$614.00M+5.7%EBITDA
$1.04B+19.7%Free Cash Flow
$793.00M+70.5%EPS (diluted)
$1.36+6.4%Shares Outstanding (diluted)
453.00M-0.4%Operating Expenses
$1.42BCash & Debt
$2.85BReturn of Capital
$16.00MRevenue by Segment (annual)
$15.23BDividend per Share
$0.04Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $20.63B | $2.08B | $4.56 |
| 2024 | $19.67B | $1.99B | $4.37 |
| 2023 | $19.55B | $1.57B | $3.04 |
| 2022 | $18.34B | $1.92B | $4.22 |
| 2021 | $17.59B | $2.25B | $4.90 |
| 2020 | $17.16B | $13.85B | $4.41 |
| 2019 | $16.63B | $1.52B | $3.35 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from GEHC's reported EPS growth of 5.3% a year over 6 years.
- EPS in 5 years
- $5.91
- Implied price
- $106.38
- Return from $80.64
- 5.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $52.89 — -34.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -4.7% | -11.8% | -7.8% | -4.3% | -1.3% | 1.3% |
| 0.3% | -7.2% | -2.9% | 0.7% | 3.8% | 6.6% |
| 5.3% | -2.5% | 1.9% | 5.7% | 9.0% | 12.0% |
| 10.3% | 2.1% | 6.8% | 10.7% | 14.2% | 17.3% |
| 15.3% | 6.7% | 11.6% | 15.7% | 19.4% | 22.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
60+20.00%Social Signal Score
Mentions (58)
- Newszacks.com·3d ago·Negative
GE HealthCare Wins FDA Nod for AI Feeding Tube Detection Software GEHC secures FDA clearance for AI-powered feeding tube detection software, expanding bedside X-ray capabilities for adult and pediatric patients.
View source ↗ - Newszacks.com·3d ago·Positive
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
View source ↗ - Newszacks.com·5d ago·Neutral
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI-powered innovations position it for long-term growth despite inflation and tariff risks.
View source ↗ - Newszacks.com·6d ago·Positive
GEHC or SYK: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
View source ↗ - Newszacks.com·9d ago·Neutral
GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research GEHC's MAGNUS Neuro Alliance aims to advance neuroscience research, expand MRI applications and develop imaging biomarkers for neurological conditions.
View source ↗ - Newszacks.com·12d ago·Neutral
GEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS GE HealthCare expands Vscan Air's AI capabilities with Lung Guidance and AutoAS, enhancing cardiopulmonary assessments and point-of-care diagnostic support.
View source ↗ - Newszacks.com·12d ago·Positive
GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy? Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newszacks.com·17d ago·Negative
GE HealthCare Unveils Allia Celeo to Advance Interventional Imaging GEHC's Allia Celeo launch expands its interventional imaging portfolio with AI-powered precision, flexible workflows and predictive service capabilities.
View source ↗ - Newsbusinesswire.com·21d ago·Neutral
… Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today introduced Allia™ Celeo,* a ceiling-mounted image guiding system, at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego. Developed around the principle of smooth procedural flow and built for interventional suites that prioritize high patient throughput and versatility across many indication…
View source ↗ - Newszacks.com·24d ago·Negative
GEHC vs. HAE: Which Stock Is the Better Value Option? Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors?
View source ↗ - Newsseekingalpha.com·24d ago·Neutral
GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling GE HealthCare Technologies delivered strong 3Q26 results, with broad-based demand, 6.2% organic revenue growth, and meaningful margin expansion. Pharmaceutical Diagnostics and Flyrcado offer attractive growth, while the SOFIE acquisition should strengthen radiopharmaceutical capabilities and future revenue streams. Raised 2026 outlook: organic revenue growth to 4%, adjusted EPS to $4.95–$5.05, and free cash flow to at least $1…
View source ↗ - News (RSS)economictimes·24d ago·Neutral
…ential future rate increases. The bond market showed fluctuations, particularly in the two-year Treasury yield post-announcement. Notably, several companies, such as GE HealthCare Technologies and Wendy's, reported better-than-expected earnings, leading to significant stock price surges.
View source ↗ - Newsmarketbeat.com·24d ago·Neutral
GE HealthCare Technologies Q3 Earnings Call Highlights GE HealthCare Technologies NASDAQ: GEHC reported third-quarter 2026 revenue growth across all of its business segments, supported by demand in imaging and pharmaceutical diagnostics, improved execution in patient care products and margin expansion.
View source ↗ - News (RSS)seekingalpha·25d ago·Neutral
GE HealthCare Technologies Inc. 2026 Q3 - Results - Earnings Call Presentation
View source ↗ - Newsbenzinga.com·25d ago·Neutral
GE HealthCare Lifts Forecasts on Healthy Hospital Spending GE HealthCare Technologies Inc. (NASDAQ:GEHC) shares rose Wednesday after the company reported third-quarter results that topped Wall Street estimates.
View source ↗ - News (RSS)zerohedge·25d ago·Neutral
…pectations on key metrics.F5 Inc. (FFIV) drops 7% after the software company’s first-quarter forecast for adjusted earnings came in below expectations.GE Healthcare (GEHC) rises 8% after the maker of X-ray equipment boosted its adjusted earnings per share guidance for the full year and posted results for the third quarter that beat the average analyst estimate.GE Vernova (GEV) is up 2% after boosting its revenue forecast for the full year. The company also agreed to pay $9 billion to acquire Tre…
View source ↗ - Newszacks.com·25d ago·Positive
GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised GE HealthCare's Q3 earnings and revenues beat estimates on strong segment growth and higher margins, driving raised 2026 guidance as shares gain 8.3%.
View source ↗ - Newszacks.com·25d ago·Negative
Compared to Estimates, GE HealthCare (GEHC) Q3 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
View source ↗ - News (RSS)seekingalpha·25d ago·Positive
GE HealthCare Technologies Non-GAAP EPS of $1.34 beats by $0.14, revenue of $5.51B beats by $160M, raises FY guidance
View source ↗ - Newszacks.com·25d ago·Positive
GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat Estimates GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $1.07 per share a year ago.
View source ↗ - Newsbusinesswire.com·25d ago·Neutral
GE HealthCare reports third quarter 2026 financial results CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered strong top-line growth and margin expansion across all segments, and robust EPS growth in the third quarter. This reflects our teams' commercial execution, disciplined operational focus enabled by Heartbeat, and continued customer adoption…
View source ↗ - Newszacks.com·31d ago·Neutral
GEHC Expands Theranostics Imaging With 5 Global Collaborations GE HealthCare expands its theranostics imaging push with five global collaborations to evaluate StarGuide GX, targeting advances in precision oncology and nuclear medicine.
View source ↗ - Newsbusinesswire.com·33d ago·Neutral
… HealthCare announces five new global collaborations to advance the next generation of theranostics imaging CHICAGO & VIENNA--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Rega…
View source ↗ - Newsbusinesswire.com·37d ago·Negative
…sthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michiganiv evaluating the use of End-tidal Control software across a large multisite academic health system in Anesthesia & Analgesia Practice. The retrospective observational study analyzed 12,818 adult general anesthesia cases performed at University …
View source ↗ - Newsglobenewswire.com·48d ago·Negative
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation BENSALEM, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.
View source ↗ - Newsbarrons.com·48d ago·Neutral
GE HealthCare Bets $945M on Fast-Growing Market With Sofie Biosciences Acquisition GE Healthcare Technologies will purchase radiopharmaceutical company Sofie Biosciences to expand into a lucrative therapeutic area.
View source ↗ - Newsglobenewswire.com·51d ago·Negative
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz LOS ANGELES, Oct. 02, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.
View source ↗ - Newszacks.com·51d ago·Neutral
GEHC vs. SYK: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
View source ↗ - Newszacks.com·53d ago·Positive
GE HealthCare (GEHC) Upgraded to Buy: Here's Why GE HealthCare (GEHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - Newszacks.com·55d ago·Positive
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now GEHC's record backlog, strong orders and AI-enabled innovations offer growth potential, while inflation and China remain key risks.
View source ↗ - News (RSS)seekingalpha·60d ago·Neutral
GE HealthCare Technologies boosts dividend by 14.3% to $0.04 a share
View source ↗ - Newsbusinesswire.com·61d ago·Negative
GE HealthCare announces cash dividend increase for third quarter of 2026 CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as of October 23, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthca…
View source ↗ - Newsbusinesswire.com·61d ago·Neutral
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership experience across finance, governance, and large-scale technology and digital transformat…
View source ↗ - News (RSS)seekingalpha·63d ago·Neutral
Key deals this week: SPGI, PSO, GEHC, and more
View source ↗ - Newsglobenewswire.com·66d ago·Negative
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation BENSALEM, Pa., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.
View source ↗ - News (RSS)yahoo·66d ago·Neutral
GE HealthCare (GEHC) Reportedly Eyes $1B Sofie Deal. What Would Ownership Add?
View source ↗ - Newsglobenewswire.com·67d ago·Negative
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.
View source ↗ - Newszacks.com·67d ago·Neutral
GEHC or SYK: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Stryker (SYK). But which of these two stocks is more attractive to value investors?
View source ↗ - Newszacks.com·67d ago·Negative
GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations GE HealthCare launches an AI-powered SaaS tool that predicts hospital capacity challenges up to 72 hours ahead and recommends actions to ease bottlenecks.
View source ↗ - Newszacks.com·67d ago·Positive
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - Newsreuters.com·70d ago·Positive
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports GE HealthCare Technologies is in talks over a possible $1 billion deal to buy radiopharmaceutical developer Sofie Biosciences, the Financial Times reported on Sunday citing people familiar with the matter.
View source ↗ - News (RSS)seekingalpha·74d ago·Positive
GE HealthCare Technologies Inc. (GEHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·74d ago·Positive
GE HealthCare Technologies Inc. (GEHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript GE HealthCare Technologies Inc. (GEHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - Newszacks.com·74d ago·Negative
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance GEHC moves StarGuide GX closer to the U.S. market with an FDA 510(k) submission, advancing its next-generation molecular imaging push.
View source ↗ - Newszacks.com·81d ago·Positive
GEHC Wins CE Mark for Photonova Spectra, Expands International Reach GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE markets.
View source ↗ - News (RSS)yahoo·81d ago·Neutral
GE HealthCare’s (GEHC) Latest Scanner Breakthrough Meets A Mixed Market
View source ↗ - Newszacks.com·83d ago·Negative
GEHC vs. HAE: Which Stock Is the Better Value Option? Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors?
View source ↗ - Newszacks.com·83d ago·Neutral
GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and cSound imaging for varied care settings.
View source ↗ - Newsbusinesswire.com·86d ago·Neutral
GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced three additions to its Vivid™ cardiovascular ultrasound portfolio – Vivid™ Explorer, Vivid™ Advanced and Vivid™ Focus.
View source ↗ - Newsbusinesswire.com·88d ago·Neutral
GE HealthCare management to present at upcoming investor conference CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference: Wells Fargo 21st Annual Health Conference – Wednesday, September 9, 2026 at 10:15 am ET/9:15am CT A webcast for the event can be accessed on the GE HealthCare website: https://investor.gehealthcare.com/news-events/events at the date and time listed above. About GE He…
View source ↗ - Newszacks.com·90d ago·Neutral
GEHC Q2 Orders Surge 11.1% as Record Backlog Builds 2027 Visibility GEHC's 11.1% order growth and record $23.9B backlog improve revenue visibility, but PCS execution and inflation remain key constraints.
View source ↗ - Newszacks.com·90d ago·Neutral
Is GEHC a Buy Now as Growth Improves but Execution Risks Persist? GEHC's valuation discount and growth in imaging and diagnostics support the case, but PCS weakness, inflation and debt keep execution risks elevated.
View source ↗ - Newszacks.com·90d ago·Positive
Here's Why You Should Add GEHC Stock to Your Portfolio for Now GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI innovation support its growth outlook despite margin pressures.
View source ↗ - Newsglobenewswire.com·94d ago·Negative
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation BENSALEM, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of federal securities laws.
View source ↗ - Newsglobenewswire.com·95d ago·Negative
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz LOS ANGELES, Aug. 19, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.
View source ↗ - Newszacks.com·101d ago·Neutral
GEHC or LMAT: Which Is the Better Value Stock Right Now? Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?
View source ↗ - Newszacks.com·102d ago·Positive
GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should Know GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newszacks.com·103d ago·Positive
GE HealthCare Technologies (GEHC) Just Overtook the 200-Day Moving Average GE HealthCare Technologies (GEHC) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GEHC broke through the 200-day moving average, which suggests a long-term bullish trend.
View source ↗
Earnings
Wed, Feb 3(in 2 months)
Consensus estimate $1.55 per share
Typical surprise +8.7% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 28$1.34 vs $1.20beat
- Wed, Jul 29$1.13 vs $1.04beat
- Wed, Apr 29$0.99 vs $1.04miss
- Wed, Feb 4$1.44 vs $1.40beat
- Wed, Oct 29$1.07 vs $1.05beat
- Wed, Jul 30$1.06 vs $0.92beat
Estimates and results for GEHC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by GEHC officers and directors.
- Bought
- $6.4m
- Sold
- —
8 trades
0 trades
- Lobo Kevinbought
- Hochman Rodney Fbought
- Yang Watkin Phoebe L.bought
- Culp H Lawrence Jrbought
- Stromberg William Jbought
- Saccaro Jamesbought
- Jimenez Frank Rbought
- Arduini Peter Jbought
92 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Nov 9, 2026 (32d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 9, 2026 (33d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (28d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 12, 2026 (41d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 12, 2026 (36d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 12, 2026 (13d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 12, 2026 (37d later)Buy$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2026 (8d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed May 13, 2026 (30d later)Buy$1,001 - $15,000
- Terri Sewellhouse · AL07 · disclosed Apr 21, 2026 (27d later)Sell$1,001 - $15,000
- Warren Davidsonhouse · OH08 · disclosed Mar 26, 2026 (3d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Austin Scotthouse · GA08 · disclosed Aug 13, 2025 (139d later)Sell$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 2, 2025 (18d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Apr 29, 2025 (21d later)Sell$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Mar 28, 2025 (31d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2023 (33d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (37d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (29d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
